AJOG MFM/LinkedIn
Dec 26, 2025, 13:09
Postpartum Readmission Rates Linked to Antihypertensive Choice – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“In a retrospective cohort of individuals with hypertensive disorders of pregnancy, discharge with labetalol rather than nifedipine was independently associated with increased risk of postpartum hospital readmission (9.2% vs 3.9%, P<.001).
Read the full text here.”
Title: Postpartum health-care utilization and blood pressure control by antihypertensive agent in hypertensive disorders of pregnancy
Authors: Carrie Bennett, Lara Lemon, Kripa Venkatakrishnan, Sanjana Ghosh, Hyagriv Simhan, Alisse Hauspurg
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 29, 2026, 19:40The Great Egg Escape: Understanding Premature Ovulation in IVF – Fertility Plus
-
May 29, 2026, 19:38Devyanshi Dixit: Call for Abstract for GFWH 2026
-
May 29, 2026, 19:35Tom Holland: Advancing Robotic Surgery Skills at the T400 Course in Strasbourg
-
May 29, 2026, 19:33Silpi Saikia: Not Every Successful Blastocyst Comes From an Easy Case!
-
May 29, 2026, 19:31Register Now and Secure Your Spot at ASRM 2026 – ASRM
-
May 29, 2026, 19:29Sonam Jain: The Real Driver of IVF Conversion Is Patient Trust
-
May 29, 2026, 19:26Mediterranean Diet Before IVF Increases Successful Pregnancies by 40%! – Fertility Plus
-
May 29, 2026, 19:24Melanie Norton: Excited to Begin My Robotics Fellowship at UCLH
-
May 29, 2026, 19:22A Step Forward in Non-Invasive Diagnosis of Endometriosis – The Lancet Medical Imaging and Theranostics